Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology will now submit comprehensive data on the safety and efficacy of the Russian vaccine candidates to the Indian authorities,India may conduct Phase 3 trials of Russian vaccine
Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology will now submit comprehensive data on the safety and efficacy of the Russian vaccine candidates to the Indian authorities,
